These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Induction of HLA-DR antigen on human squamous carcinoma by recombinant interferon gamma. Koch WM; Dugan E; Diaz LA; Richtsmeier WJ Laryngoscope; 1988 May; 98(5):511-5. PubMed ID: 3129628 [TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells. Giacomini P; Aguzzi A; Ferrone S Hybridoma; 1986; 5(4):277-88. PubMed ID: 3100420 [TBL] [Abstract][Full Text] [Related]
4. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. Muczynski KA; Anderson SK; Pious D J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276 [TBL] [Abstract][Full Text] [Related]
5. Modulation of MHC class II expression in human cells by dexamethasone. Schwiebert LM; Schleimer RP; Radka SF; Ono SJ Cell Immunol; 1995 Oct; 165(1):12-9. PubMed ID: 7671315 [TBL] [Abstract][Full Text] [Related]
6. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1. Love KS; Lakshmanan RR; Butterfield JH; Fox CC Cell Immunol; 1996 May; 170(1):85-90. PubMed ID: 8660803 [TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of HLA-DR antigens by the human melanoma cell line CaCL 73-36 upon induction of a less differentiated phenotype with bromodeoxyuridine. Kawakubo Y; Liao SK Anticancer Res; 1986; 6(5):1197-204. PubMed ID: 3800326 [TBL] [Abstract][Full Text] [Related]
8. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression. Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395 [TBL] [Abstract][Full Text] [Related]
9. Recombinant gamma interferon induces HLA-DR expression on squamous cell carcinoma, trichilemmoma, adenocarcinoma cell lines, and cultured human keratinocytes. Kameyama K; Tone T; Eto H; Takezaki S; Kanzaki T; Nishiyama S Arch Dermatol Res; 1987; 279(3):161-6. PubMed ID: 2439027 [TBL] [Abstract][Full Text] [Related]
10. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells. Ranella A; Vassiliadis S; Mastora C; Valentina M; Dionyssopoulou E; Athanassakis I Hum Immunol; 2005 Jan; 66(1):43-55. PubMed ID: 15620461 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes. Moriya N; Sanjoh K; Yokoyama S; Hayashi T J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214 [TBL] [Abstract][Full Text] [Related]
12. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. Shaw AR; Chan JK; Reid S; Seehafer J J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246 [TBL] [Abstract][Full Text] [Related]
13. HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Pallone F; Fais S; Capobianchi MR Clin Exp Immunol; 1988 Oct; 74(1):75-9. PubMed ID: 3146453 [TBL] [Abstract][Full Text] [Related]
14. Expression and in-vitro modulation of HLA antigens in ontogenic development of human hemopoietic system. Gabbianelli M; Boccoli G; Petti S; Cianetti L; La Valle R; Ferbus D; Mastroberardino G; Testa U; Peschle C Ann N Y Acad Sci; 1987; 511():138-47. PubMed ID: 3125777 [No Abstract] [Full Text] [Related]
15. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells. Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000 [TBL] [Abstract][Full Text] [Related]
16. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression. Lin HY; Martino LJ; Wilcox BD; Davis FB; Gordinier JK; Davis PJ J Immunol; 1998 Jul; 161(2):843-9. PubMed ID: 9670962 [TBL] [Abstract][Full Text] [Related]
17. HLA-DR expression in a human colonic carcinoma cell line. Lampert IA; Kirkland S; Farrell S; Borysiewicz LK J Pathol; 1985 Aug; 146(4):337-44. PubMed ID: 3928856 [TBL] [Abstract][Full Text] [Related]
18. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity. Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958 [TBL] [Abstract][Full Text] [Related]
19. Amplified T cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes. Tjernlund U; Scheynius A Acta Derm Venereol Suppl (Stockh); 1988; 135():57. PubMed ID: 3259359 [No Abstract] [Full Text] [Related]
20. Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes. Spurrell DR; Oldford SA; Frost T; Larsen B; Codner D; Edgecombe A; Drover S Hum Immunol; 2004 Dec; 65(12):1516-29. PubMed ID: 15603880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]